C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/81 (2006.01) A61K 38/17 (2006.01) A61K 38/57 (2006.01) A61P 35/00 (2006.01) C07K 14/47 (2006.01) C12N 9/64 (2006.01)
Patent
CA 2441695
Matrix metalloproteinases (MMPs) play an important role in morphogenesis, angiogenesis, wound healing, and in certain disorders such as rheumatoid arthritis, tumor invasion and metastasis. MMPs are thought to be regulated by a variety of cytokines, growth factors, hormones and phorbol esters. This regulation occurs on three levels; alteration of gene expression, activation of the latent zymogen and inhibition by the tissue inhibitors of metalloproteinases (TIMP). We report here a new agent that regulates the level of MMPs in patient. More particularly, members of the PSP94 family, when administered to patients having metastatic hormone resistant prostate cancer, promote a significant decrease in MMP plasma levels. The invention therefore relates to the use of a PSP94 family member for the treatment of a condition related to the activity or expression of MMPs.
No affiliations
Bkp Gp
Procyon Biopharma Inc.
Unknown
LandOfFree
Regulation of matrix metalloproteinases by psp94 family members does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of matrix metalloproteinases by psp94 family members, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of matrix metalloproteinases by psp94 family members will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2073164